Negative interference by rheumatoid factor of plasma B-type natriuretic peptide in chemiluminescent microparticle immunoassays.
BACKGROUND: The chemiluminescent microparticle immunoassay (CMIA) is widely used for the quantitative determination of B-type natriuretic peptide (BNP) in human ethylenediaminetetraacetic acid plasma. Rheumatoid factor (RF) is usually thought to result in a positive interference in immunoassays, but...
Main Authors: | Wen Fan, Lei Xu, Liangcai Xie, Decai Yang, Xuezheng Liu, Jiajun Zhang, Yirong Li, Cunjian Yi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4140727?pdf=render |
Similar Items
-
Comparison of chemiluminescent microparticle immunoassay (CMIA) with electrochemiluminescence immunoassay (ECLIA) for Carcinoembryonic antigen (CEA)
by: Nafija Serdarevic, et al.
Published: (2018-09-01) -
Novel chemiluminescence immunoassays
by: Richardson, A. P.
Published: (1984) -
Metalloporphyrin : catalysed chemiluminescence immunoassay
by: Bashirians, George Mamberi
Published: (1993) -
Comparison of chemiluminescence enzyme immunoassay based on magnetic microparticles with traditional colorimetric ELISA for the detection of serum α-fetoprotein
by: Qian-Yun Zhang, et al.
Published: (2012-04-01) -
Development of chemiluminescence immunoassay for the measurement of plasma steroids and urinary steroid glucuronides
by: Kim, Jong Bae
Published: (1983)